Skip to content

Clinical trials

Hypertension, Pulmonary trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Country / region: Australia Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20042
20063
20084
20095
20102
20121
20142
20151
20161
20171
20182
20193
20202
20213
20221
20232
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated7
Active, not recruiting5
Recruiting4
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
Gilead Sciences6
United Therapeutics6
Actelion3
Insmed Incorporated3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Biogen2
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
Respira Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary45
Pulmonary Arterial Hypertension22
Lung Diseases, Interstitial6
Cardiovascular Diseases5
Familial Primary Pulmonary Hypertension5
Lung Diseases5
Vascular Diseases5
Respiratory Tract Diseases4
Hypertension3
Connective Tissue Diseases2

Trials

Showing 76 to 45 of 45. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.